MAPT and cancer: This is, to the best of our knowledge, the first study that supports that BAT exerts a superior anti-proliferative effect in a wide spectrum of cancer cells compared to that of Tau, whereas both agents exerted minimal cytotoxicity in normal cells (WJ-MSCs) in the concentrations tested, given the high biocompatibility index of BAT [45].